Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.07. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.07.2024 | 749 | Xetra Newsboard | The following instruments on XETRA do have their first trading 30.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.07.2024
Aktien
1 US1712691039 Chugai Pharmaceutical... ► Artikel lesen | |
24.06. | Chugai Pharmaceutical-Aktie heute gut behauptet: Aktienwert steigt (31,305 €) | 396 | ARIVA.de | An der Börse notiert die Chugai Pharmaceutical-Aktie gegenwärtig etwas fester. Das Wertpapier notiert aktuell bei 31,31 Euro. Der Anteilsschein von Chugai Pharmaceutical verzeichnet derzeit einen Preisanstieg... ► Artikel lesen | |
CHUGAI PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln | |||||
12.06. | Helsinn Healthcare S.A.: Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland | 801 | GlobeNewswire (Europe) | Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland
Lugano, Switzerland - June 12, 2024 - Helsinn Group ("Helsinn"), a global... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TRULIEVE CANNABIS | 5,890 | -1,75 % | Trulieve Cannabis Corp: Trulieve opens two new dispensaries in Florida | ||
WEST PHARMACEUTICAL SERVICES | 302,40 | +2,20 % | Kursgewinne für die Aktie von West Pharmaceutical Services (292,3337 €) | An der US-amerikanischen Börse liegt die Aktie von West Pharmaceutical Services zur Stunde im Plus. Das Papier kostete zuletzt 308,07 US-Dollar. Heute hat sich am US-amerikanischen Aktienmarkt das Wertpapier... ► Artikel lesen | |
SHIONOGI | 12,500 | -1,57 % | Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ in Japan | QUVIVIQ is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomnia Tokyo, Japan and Cambridge, UK, 1 October 2024... ► Artikel lesen | |
HERITAGE CANNABIS | 0,001 | 0,00 % | Heritage Cannabis Holdings Corp.: Heritage Cannabis Announces Completion of Sale and Delisting from the CSE and the OTCQX | TORONTO, Aug. 29, 2024 /CNW/ - Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) ("Heritage" or the "Company") today announces, that, in connection with its creditor protection proceedings... ► Artikel lesen | |
KALA BIO | 6,040 | +1,00 % | KALA BIO, Inc. - 10-Q, Quarterly Report | ||
CHARLOTTES WEB | 0,121 | -3,97 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2024 Third quarter Financial Results | Sequential quarterly growth returns for 2024 New Product Innovations Driving Omni-Channel Expansion
LOUISVILLE, Colo., Nov. 14, 2024 /PRNewswire/ - (TSX: CWEB... ► Artikel lesen | |
BEXIMCO | 0,360 | 0,00 % | Government intervenes with emergency loan package to resolve Beximco labour unrest | ||
LUYE PHARMA | 0,312 | +0,65 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR CLASS 1 INNOVATIVE ANTIDEPRESSANT LY03021 FOR CLINICAL TRIALS IN CHINA | ||
MIRUM PHARMACEUTICALS | 42,200 | +1,93 % | Mirum Pharmaceuticals (NASDAQ:MIRM) Trading Down 4.6% After Insider Selling | ||
GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc. - 8-K, Current Report | ||
PERCHERON THERAPEUTICS | 0,048 | -1,03 % | PERCHERON THERAPEUTICS LIMITED: Proposed issue of securities - PER | ||
AYURCANN | 0,017 | +3,03 % | Ayurcann Holdings Corp.: Ayurcann Terminates Business Combination | Toronto, Ontario, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company"), a leading Canadian processing and manufacturing company specializing... ► Artikel lesen | |
KALBE FARMA | 0,079 | -0,63 % | KLBF strengthens prescription drug business by inaugurating radioisotope factory: PT Kalbe Farma Tbk ... | ||
EVEREST MEDICINES | 4,520 | -1,74 % | Everest Medicines Limited: Everest Medicines Announces NEFECON(R)'s Full Approval in South Korea | - Marking Another Milestone in CommercializationHONG KONG, Nov 19, 2024 - (ACN Newswire) - Today, Everest Medicines announced that NEFECON(R) has received full approval from the Ministry of Food and... ► Artikel lesen | |
AVANT BRANDS | 0,388 | +11,49 % | Avant Brands Inc.: Avant Brands Announces Results for Q3 2024 | Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million... ► Artikel lesen |